Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 3/20 | 0.40 |
| ▸ | CDK9 | P50750 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.37 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.37 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | MLYCD | O95822 | 1/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30765173 | 0.91 | TNKS (0.43) | HPGDRIPK1KCNH2MKNK1MKNK2 | |
| SCHEMBL32672561 | 0.89 | GLRA1 (0.38) | — | |
| SCHEMBL32672619 | 0.89 | GLRA1 (0.38) | — | |
| SCHEMBL30765407 | 0.88 | TGFBR1 (0.42) | CCNT1CDK9HPGDRIPK1KCNH2 | |
| SCHEMBL27262365 | 0.88 | TGFBR1 (0.42) | CCNT1CDK9HPGDRIPK1KCNH2 | |
| SCHEMBL32672571 | 0.87 | MKNK1 (0.40) | HPGDRIPK1KCNH2HRH3MKNK1 | |
| SCHEMBL32672591 | 0.87 | PIK3C3 (0.34) | LRRK2 | |
| SCHEMBL27262683 | 0.87 | VNN1 (0.35) | HRH3LRRK2 | |
| SCHEMBL27262758 | 0.87 | VNN1 (0.35) | HRH3LRRK2 | |
| SCHEMBL32672657 | 0.86 | NPC1 (0.42) | HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042772-A1 | FURO PYRIMIDINE DERIVATES | MERCK PATENT GMBH (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4568970-A1 | FURO PYRIMIDINE DERIVATES | Merck Patent GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| CN-119948032-A | Furanopyrimidine derivatives | 默克专利股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2024033281-A1 | FURO PYRIMIDINE DERIVATES | MERCK PATENT GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |
| WO-2024033280-A1 | FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA | MERCK PATENT GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042772-A1 | FURO PYRIMIDINE DERIVATES | HAVCR2, CYC1, CNKSR1 | CCNT1 2674/4885CDK9 2355/4885HPGD 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.